|
Suche
Website
Website
Staff
Publications
|
||
Marino ZerialOngoing Projects The following subprojects will give more detailed information on
Simonsen et al. (1998) Chistoforidis et al. (1999) Rubino et al. (2000)
McBride et al. (1999) A second interaction between a Rab5 effector and SNAREs was provided by the functional characterization of Rabenosyn-5. Like EEA1, Rabenosyn-5 contains a FYVE-finger domain and is recruited in a phosphatidylinositol-3-kinase dependent fashion to early endosomes. Rabenosyn-5 is complexed to the previously identified Sec1-like protein, hVPS45. Sec1 family members are thought to “present” syntaxins to other SNARE complex members. In the case of endosomal SNAREs, this function would be contributed by Rabenosyn-5 through its interaction with hVPS45. Consistent with a role of modulating SNARE prtiming and pairing, we found that hVPS45 can directly bind multiple syntaxin family members. Nielsen et al. (2000)
We have identified two distinct PI 3-Ks, hVPS34/p150 and p85-alpha/p110-beta among the Rab5 effectors and we have recently demonstrated that PI(3)P is regulated by Rab5 (Hye-Won Shin et al. in preparation). An important implication of our work is that Rab5 mediates the recruitment of EEA1 not only by binding directly to this protein but also catalytically, through an interaction with hVPS34/p150. Whereas production of PI(3)P primarily depends on the activity of hVPS34/p150, also PI 3-K-beta contributes to this activity. This is surprising in view of the fact that Type I PI 3-K produce PI(3,4,5)P3 instead of PI(3)P. Once again, the explanation came from the analysis of the Rab5 affinity column eluate. We established that also PI5-phosphatase and PI4-phosphatase are Rab5 effectors and that, in addition to direct phosporylation of PI, turnover of PI(3,4,5)P3 accounts for the synthesis of PI(3)P on early endosomes. We believe this system is designed to convert excess of PI(3,4,5)P3 and PI(3,4)P2 transiently produced at the plasma membrane e.g. during signaling, into the PI species, i.e. PI(3)P necessary to maintain the organization and function of early endosomes. Christoforidis et al. (1999) The identification of PI 3-Ks as Rab5 effectors illustrates once more the cooperativity among these molecules. Collectively, these data led us to propose a model to explain the organization of early endosomes based on the clustering of Rab5 and its effectors in a distinct membrane sub-compartment. Briefly, the membrane domain is based on 1) the localized production of PI(3)P, 2) on the cooperativity among rab5 effectors and 3) on their oligomerization properties that limit their diffusion. NSF regulates the oligomerization of the Rab effectors and the transition from membrane docking to fusion, by a yet unknown mechanism. The unique features of these membrane domains, i.e. size, biochemical composition, localization and functional properties, suggest that Rab5 and its effectors may play a central role not only in the regulation of membrane trafficking to early endosomes but also in the biogenesis of this organelle. Vitale et al. (1998) Sönnichsen et al. (2000) Zerial and McBride (2001) Miaczynska and Zerial (2002) De Renzis et al. (2002)
We propose that the interaction of Rab5:GTP with hVPS34 results in a localized production of PI-3P that, combined with the recruitment of Rab5 effectors contributes to the formation of aformation of a PI(3)P-enriched “Rab5-domain” on the endosomal membrane could localize a microtubule motor. We have recently identified a candidate motor protein that may fulfill the criteria for Rab5 and PI(3)P-dependent endosome movement along microtubules. We have previously found that early endosomes move bi-directionally between the cell periphery and the interior through a mechanism regulated by the small GTPase RhoD. We identified a novel splice variant of human Diaphanous, hDia2C, which specifically binds to RhoD and is recruited on early endosomes. Expression of RhoD and hDia2C induces a striking alignment of early endosomes along actin filaments and reduces their motility. This activity depends on the membrane recruitment and activation of c-Src kinase, thus uncovering a new role in endosome function. Thus, a novel signal transduction pathway where hDia2C and c-Src are sequentially activated by RhoD regulates the motility of early endosomes via interaction with the actin cytsoskeleton. In conclusion both Rab5 and RhoD concur to regulate endosome localization and movement within the cell, via processes regulated by both the actin and tubulin cytoskeleton. Nielsen et al. (1999) Gasman et al. (2003)
A central aim of the group is to test the Rab-domain model of endosome biogenesis. This will be accomplished by analyzing the dynamics of Rab-domains in vivo and by functionally characterizing novel effectors for Rab GTPases that play a role in endocytosis and recycling. The studies in vivo will address the question of whether Rab-domains are stable in time or can be formed de-novo and undergo maturation. This question is very important in the context of the “vesicular transport” versus “endosome maturation” models. It is also important with respect to organelle inheritance during mitosis (see below). Affinity chromatography approaches similar to the one successfully used for Rab5 have been employed to identify downstream interactors of Rab4, Rab11 and Rab7. We value with particular interest the identification of divalent effectors for these GTPases, in order to test the Rab-domain hypothesis. The data so far obtained are extremely encouraging in this respect. Furthermore, we have systematically expressed the Rab5 effectors as recombinant proteins aiming at reconstituting the Rab5 machinery in proteoliposomes. The goal of this project is to assemble artificial early endosomes using purified components and reconstitute the minimal machinery that is capable of Rab-dependent membrane fusion and motility in vitro. This approach will not only enable a more detailed study on the functional relationship between Rab effectors and SNAREs, but will also address the mechanism of membrane segregation regulated by Rab5 and its downstream effectors. To elucidate the mechanisms regulating endocytosis in polarised cells. This aim includes the characterization of Rab effectors participating in polarised endocytic transport. For example, the Rab5 effector Rabankyrin-5 regulates apical but not basolateral endocytic uptake in polarized epithelial cells. We will explore the role of various Rab effectors, especially those so far uncharacterized, in polarised trafficking. However, beyond the analysis of Rab effectors, we aim at identifying and functionally characterizing novel molecules regulating endocytic transport using genetically amenable organisms, e.g. C. elegans, D. melanogaster (with S. Eaton and M. Gonzalez) and mice (Frank Buchholz). This will be accomplished with the technical support of the assay development and screening facility of the MPI-CBG that will enable us to perform genome-wide RNAi screenings. An important aspect of the study of endosome biogenesis is to elucidate the mechanisms regulating microtubule-dependent endosome motility and partitioning between daughter cells during mitosis. New assays have been designed to investigate this problem both in vitro and in vivo. The identification of a motor protein that specifically interacts with PI(3)P and is recruited on the early endosome membrane provides us with a molecular tool to begin the functional dissection of this process. The role of Rab GTPases in the structural and functional organization of endosomes has profound implications for how endocytic transport is modulated by signalling molecules and, conversely, how the endocytic machinery modulates the responsiveness of cells to signalling. For example, stimulation by EGF enhances the rate of endocytic membrane flow by increasing the fraction of active Rab5. We have recently discovered two novel Rab5 effectors, APPL1 and APPL2, that are excellent candidates for molecules linking endocytic trafficking to signalling. APPL1 and 2 reside on a novel intracellular vesicle or organelle, the hermesome. We have shown that the hermesome functions as a specialized endosome devoted to signalling from the plasma membrane to the nucleus. An important task is now to elucidate the role of this new compartment in the interface between signalling and endocytosis. Questions that will be addressed are: Which specific physiological role does this organelle exert in signal transduction? How is transport to the hermesome vs. endosome regulated? Do hermesomes and endosomes communicate and how? What is the role of Rab5 in this process? What is the link between APPL and endocytosis in cell proliferation? Do hermesomes have a widespread role? Do other growth factors use the hermesome signaling pathway? To what extent this pathway regulates proliferation vs. differentiation in different cell types? We expect that progress along these lines will reveal novel insights into the molecular principles of endosome functions in trafficking, signalling and in the establishment and maintenance of cell polarity. Lanzetti, L., Rybin, V., Malabarba, M.G., Christoforidis, S., Scita, G., Zerial, M., and Di Fiore, P.P. (2000) |
||
| © 2008-2010 MPI-CBG, Impressum, Intranet | ||